Arch Therapeutics, Inc.

CIK 1537561 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Arch Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jan 12, 202615-12G0001537561-26-000002
May 23, 20258-K0001641172-25-012288
May 23, 2025RW0001641172-25-012268
Feb 7, 20258-K0001493152-25-005383
Jan 23, 20258-K0001493152-25-003400
Dec 31, 2024NT 10-K0001493152-24-052705
Nov 13, 2024SC 13G/A0000921895-24-002635
Nov 7, 20248-K0001493152-24-044026
Nov 4, 20248-K0001493152-24-043518
Sep 26, 20248-K0001493152-24-038340
Sep 19, 20248-K0001493152-24-037130
Sep 13, 20248-K0001493152-24-036208
Aug 30, 20248-K0001493152-24-034600
Aug 20, 20248-K0001493152-24-033295
Aug 19, 202410-Q0001493152-24-033091
Aug 16, 20248-K0001493152-24-032873
Aug 16, 20248-K0001493152-24-032876
Aug 14, 2024NT 10-Q0001493152-24-032353
Aug 2, 20248-K0001493152-24-030082
Jul 22, 20248-K0001493152-24-028684
Jul 5, 20248-K0001493152-24-026379
Jun 28, 20248-K0001493152-24-025625
Jun 25, 20248-K0001493152-24-025116
Jun 20, 2024S-1/A0001493152-24-024562
Jun 18, 20248-K0001493152-24-024285